CONGRESS | #IMS23 | Darrell White @DalhousieU presents safety and efficacy data for IberVd in transplant-ineligible NDMM.
Neutropenia 35.3%, thrombocytopenia 29.4% infections 76.5%
ITT population ORR 100%, ≥CR 56.25%, ≥VGPR 87.5%
#IMS2023#myeloma#mmsm